| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.02 | 0.9 |